Invention Grant
US09579398B2 Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
有权
FAM19A5的药物用途涉及调节胶质细胞发生
- Patent Title: Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
- Patent Title (中): FAM19A5的药物用途涉及调节胶质细胞发生
-
Application No.: US14378505Application Date: 2013-02-15
-
Publication No.: US09579398B2Publication Date: 2017-02-28
- Inventor: Jae Young Seong , Jong Ik Hwang , Woong Sun , Eun Bee Cho , Won-ki Kim
- Applicant: Neuracle Science Co., Ltd.
- Applicant Address: KR Seoul
- Assignee: Neuracle Science Co., Ltd.
- Current Assignee: Neuracle Science Co., Ltd.
- Current Assignee Address: KR Seoul
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: KR10-2012-0015177 20120215; KR10-2013-0016094 20130215
- International Application: PCT/KR2013/001179 WO 20130215
- International Announcement: WO2013/122408 WO 20130822
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61P25/00 ; A61K48/00 ; A61K38/17 ; C07K16/18 ; C12N15/113 ; C07K14/47 ; C07K16/24 ; C12Q1/68 ; A61K39/00
Abstract:
The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.
Public/Granted literature
- US20150118230A1 Pharmaceutical Use of FAM19A5 Involved in Regulating Gliogenesis Public/Granted day:2015-04-30
Information query
